Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Yarui, Huang"'
Autor:
Chengxin Luo, Xiangtao Huang, Ling Wei, Guixian Wu, Yarui Huang, Yaqun Ding, Zhen Huang, Jieping Chen, Xi Li, Yunding Zou, Shuangnian Xu
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
ObjectiveSteroids-refractory (SR) acute graft-versus-host disease (aGVHD) is a life-threatening condition in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), but the optimal second-line therapy still has not been es
Externí odkaz:
https://doaj.org/article/e66f50146f0d4e6192233a60304994ac
Autor:
Chengxin Luo, Guixian Wu, Xiangtao Huang, Yali Zhang, Yanni Ma, Yarui Huang, Zhen Huang, Hui Li, Yu Hou, Jieping Chen, Xi Li, Shuangnian Xu
Publikováno v:
Stem Cell Research & Therapy, Vol 13, Iss 1, Pp 1-19 (2022)
Abstract Background Efficient mobilization of hematopoietic stem cells (HSCs) from bone marrow niche into circulation is the key to successful collection and transplantation in patients with hematological malignancies. The efficacy of various HSCs mo
Externí odkaz:
https://doaj.org/article/fb75744253b54d189ed38f745d63700b
Autor:
Chengxin Luo, Li Wang, Guixian Wu, Xiangtao Huang, Yali Zhang, Yanni Ma, Mingling Xie, Yanni Sun, Yarui Huang, Zhen Huang, Qiuyue Song, Hui Li, Yu Hou, Xi Li, Shuangnian Xu, Jieping Chen
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-19 (2021)
Abstract Background Mobilization failure may occur when the conventional hematopoietic stem cells (HSCs) mobilization agent granulocyte colony-stimulating factor (G-CSF) is used alone, new regimens were developed to improve mobilization efficacy. Mul
Externí odkaz:
https://doaj.org/article/ce2a93733562408fbaacf882d5f796a0
Autor:
Chengxin Luo, Guixian Wu, Xiangtao Huang, Yanni Ma, Yali Zhang, Qiuyue Song, Mingling Xie, Yanni Sun, Yarui Huang, Zhen Huang, Yu Hou, Shuangnian Xu, Jieping Chen, Xi Li
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Rituximab combined with chemotherapy is the first-line induction therapy of CD20 positive B-cell non-Hodgkin lymphomas (CD20+ B-NHL). Recently new anti-CD20 monoclonal antibodies (mAbs) have been developed, but their efficacy and safety comp
Externí odkaz:
https://doaj.org/article/09e7bf5118624eba86020226d2018c5e
Autor:
Chengxin Luo, Guixian Wu, Xiangtao Huang, Yaqun Ding, Yarui Huang, Qiuyue Song, Yu Hou, Jieping Chen, Xi Li, Shuangnian Xu
Publikováno v:
Bone Marrow Transplantation. 58:175-185
The optimal myeloablative conditioning (MAC) regimens in adult patients with acute myeloid leukemia (AML) undergoing allogeneic hemopoietic stem cell transplantation (allo-HSCT) in complete remission (CR) remain unclear. We performed a systematic rev
Autor:
Yaqun Ding, Xiangyu Qi, Yang Li, Yanni Sun, Jia Wan, Chengxin Luo, Yarui Huang, Qingrong Li, Guixian Wu, Xiaoqing Zhu, Shuangnian Xu
Inflammation and nutrition related proteins participate in the development of acute myeloid leukemia (AML). It has been reported that the albumin-to-fibrinogen ratio (AFR) could serve as a prognostic indicator in patients with malignancy, but the pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83f10ad996dd71e9c60d67034e8c7e6f
https://doi.org/10.21203/rs.3.rs-2610172/v1
https://doi.org/10.21203/rs.3.rs-2610172/v1
Autor:
Xi Li, Qingrong Li, Jieping Chen, Yali Zhang, Yanni Sun, Xiangtao Huang, Yarui Huang, Yanni Ma, Zhen Huang, Chengxin Luo, Mingling Xie, Shuangnian Xu, Guixian Wu
Publikováno v:
Annals of Transplantation
Background High-dose chemotherapy followed by autologous stem cell transplantation (HDT/ASCT) plays a crucial role in the therapy of patients with lymphoma. This retrospective study aimed to analyze prognostic factors in patients undergoing HDT/ASCT
Autor:
Qiuyue Song, Yanni Sun, Xiangtao Huang, Shuangnian Xu, Yu Hou, Yali Zhang, Chengxin Luo, Yanni Ma, Yarui Huang, Xi Li, Jieping Chen, Li Wang, Hui Li, Zhen Huang, Guixian Wu, Mingling Xie
Publikováno v:
Stem Cell Research & Therapy
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-19 (2021)
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-19 (2021)
Background Mobilization failure may occur when the conventional hematopoietic stem cells (HSCs) mobilization agent granulocyte colony-stimulating factor (G-CSF) is used alone, new regimens were developed to improve mobilization efficacy. Multiple stu
Autor:
Qiuyue Song, Jieping Chen, Yarui Huang, Yanni Sun, Zhen Huang, Yanni Ma, Xiangtao Huang, Xi Li, Yu Hou, Shuangnian Xu, Mingling Xie, Yali Zhang, Guixian Wu, Chengxin Luo
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Rituximab combined with chemotherapy is the first-line induction therapy of CD20 positive B-cell non-Hodgkin lymphomas (CD20+ B-NHL). Recently new anti-CD20 monoclonal antibodies (mAbs) have been developed, but their efficacy and safety compared with
Autor:
Chengxin, Luo, Guixian, Wu, Xiangtao, Huang, Yanni, Ma, Yali, Zhang, Qiuyue, Song, Mingling, Xie, Yanni, Sun, Yarui, Huang, Zhen, Huang, Yu, Hou, Shuangnian, Xu, Jieping, Chen, Xi, Li
Publikováno v:
Scientific Reports
Rituximab combined with chemotherapy is the first-line induction therapy of CD20 positive B-cell non-Hodgkin lymphomas (CD20+ B-NHL). Recently new anti-CD20 monoclonal antibodies (mAbs) have been developed, but their efficacy and safety compared with